See All Slides - tctmd.com

Slides

Presentation TCT 2012

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

Presenter: James Hermiller Jr

October 23, 2012

Presentation TCT 2012

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

Presenter: Timothy Henry

October 23, 2012

Presentation TCT 2012

CABG Will Always Be the Preferred Approach!

Presenter: Friedrich Mohr

October 23, 2012

Presentation TCT 2012

Most Diseases Are Systemic: It's the Focal Manifestations that Count!

Presenter: James Muller

October 23, 2012

Presentation TCT 2012

TCT-77. Initial and Mid-Term Angiographic Outcomes of Septal Channel Perforation Related to Retrograde Recanalization for Chronic Total Occlusions

Presenter: Hiroyuki Tanaka

October 23, 2012

Presentation TCT 2012

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

Counterpulsation for Chronic Heart Failure: Sunshine

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Advertisement

Slides

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

CABG Will Always Be the Preferred Approach!

Most Diseases Are Systemic: It's the Focal Manifestations that Count!

TCT-77. Initial and Mid-Term Angiographic Outcomes of Septal Channel Perforation Related to Retrograde Recanalization for Chronic Total Occlusions

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Counterpulsation for Chronic Heart Failure: Sunshine

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Lifetech LAA Closure Device: Description and Preclinical Results

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content